186 related articles for article (PubMed ID: 32181519)
1. Quercetin prevents alterations of behavioral parameters, delta-aminolevulinic dehydratase activity, and oxidative damage in brain of rats in a prenatal model of autism.
de Mattos BDS; Soares MSP; Spohr L; Pedra NS; Teixeira FC; de Souza AA; Stefanello FM; Baldissarelli J; Gamaro GD; Spanevello RM
Int J Dev Neurosci; 2020 Jun; 80(4):287-302. PubMed ID: 32181519
[TBL] [Abstract][Full Text] [Related]
2. Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism.
Khalaj R; Hajizadeh Moghaddam A; Zare M
Int J Dev Neurosci; 2018 Oct; 69():80-87. PubMed ID: 29966739
[TBL] [Abstract][Full Text] [Related]
3. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
4. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
Schneider T; Przewłocki R
Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
6. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
[TBL] [Abstract][Full Text] [Related]
7. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
Matsuo K; Yabuki Y; Fukunaga K
Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
[TBL] [Abstract][Full Text] [Related]
8. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
Kumar H; Sharma BM; Sharma B
Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
[TBL] [Abstract][Full Text] [Related]
9. Saffron and crocin ameliorate prenatal valproic acid-induced autistic-like behaviors and brain oxidative stress in the male offspring rats.
Seyedinia SA; Tarahomi P; Abbarin D; Sedaghat K; Rashidy-Pour A; Yaribeygi H; Vafaei AA; Raise-Abdullahi P
Metab Brain Dis; 2023 Oct; 38(7):2231-2241. PubMed ID: 37566156
[TBL] [Abstract][Full Text] [Related]
10. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
11. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters.
Bambini-Junior V; Rodrigues L; Behr GA; Moreira JC; Riesgo R; Gottfried C
Brain Res; 2011 Aug; 1408():8-16. PubMed ID: 21767826
[TBL] [Abstract][Full Text] [Related]
12. Prenatal pregabalin is associated with sex-dependent alterations in some behavioral parameters in valproic acid-induced autism in rat offspring.
Shamsi Meymandi M; Sepehri G; Moslemizadeh A; Vakili Shahrbabaki S; Bashiri H
Int J Dev Neurosci; 2020 Oct; 80(6):500-511. PubMed ID: 32588482
[TBL] [Abstract][Full Text] [Related]
13. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism.
Al-Amin MM; Rahman MM; Khan FR; Zaman F; Mahmud Reza H
Behav Brain Res; 2015 Jun; 286():112-21. PubMed ID: 25732953
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
Mirza R; Sharma B
Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
[TBL] [Abstract][Full Text] [Related]
15. Quercetin protects the impairment of memory and anxiogenic-like behavior in rats exposed to cadmium: Possible involvement of the acetylcholinesterase and Na(+),K(+)-ATPase activities.
Abdalla FH; Schmatz R; Cardoso AM; Carvalho FB; Baldissarelli J; de Oliveira JS; Rosa MM; Gonçalves Nunes MA; Rubin MA; da Cruz IB; Barbisan F; Dressler VL; Pereira LB; Schetinger MR; Morsch VM; Gonçalves JF; Mazzanti CM
Physiol Behav; 2014 Aug; 135():152-67. PubMed ID: 24952260
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Luhach K; Kulkarni GT; Singh VP; Sharma B
J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
[TBL] [Abstract][Full Text] [Related]
18. Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.
Hirsch MM; Deckmann I; Fontes-Dutra M; Bauer-Negrini G; Della-Flora Nunes G; Nunes W; Rabelo B; Riesgo R; Margis R; Bambini-Junior V; Gottfried C
Food Chem Toxicol; 2018 May; 115():336-343. PubMed ID: 29510222
[TBL] [Abstract][Full Text] [Related]
19. TCHis mitigate oxidative stress and improve abnormal behavior in a prenatal valproic acid-exposed rat model of autism.
Jian J; Li LG; Zhao PJ; Zheng RJ; Dong XW; Zhao YH; Yin BQ; Cheng H; Li HL; Li EY
Physiol Genomics; 2022 Sep; 54(9):325-336. PubMed ID: 35723222
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
